Your browser doesn't support javascript.
loading
Show: 20 | 50 | 100
Results 1 - 2 de 2
Filter
Add more filters











Database
Language
Publication year range
1.
J Investig Med High Impact Case Rep ; 12: 23247096241253343, 2024.
Article in English | MEDLINE | ID: mdl-38767131

ABSTRACT

The association between Hairy Cell Leukemia (HCL) and non-tuberculous mycobacterial infections (NTMs) is well described, most notably Mycobacterium kansasii. The exact pathophysiology is not known. We report a case of a 31-year-old male with concomitantly diagnosed HCL and disseminated M kansasii infection who presented with rash, pancytopenia, and bulky axillary lymphadenopathy. The M kansasii was initially diagnosed through use of cell-free DNA detection and confirmed by bone marrow and lymph node cultures. Hairy Cell Leukemia was diagnosed with peripheral flow cytometry and confirmed via the same bone marrow sample. His HCL was put into remission with a single course of cladribine and rituximab chemotherapy; however, his M kansasii infection persisted for 6 months despite aggressive antimicrobial and surgical therapy. It was finally controlled using high-dose rifampin in combination with azithromycin and ethambutol. This case highlights the known link between HCL and M kansasii. Furthermore, it hints at potential causes beyond chemotherapy-induced immunocompromise. Notable possibilities include HCL cells acting as sanctuary sites for M kansasii to evade the immune system, and subclinical M kansasii infections causing NLRP3 inflammasome overactivation to trigger the oncogenic transformation to HCL. More research into the pathophysiologic link between HCL and M kansasii infections would allow for more effective prevention, diagnosis, and treatment of these severe atypical infections which are the major cause of morbidity in the cladribine era of HCL treatment.


Subject(s)
Leukemia, Hairy Cell , Mycobacterium Infections, Nontuberculous , Mycobacterium kansasii , Humans , Male , Leukemia, Hairy Cell/complications , Leukemia, Hairy Cell/diagnosis , Leukemia, Hairy Cell/drug therapy , Adult , Mycobacterium Infections, Nontuberculous/diagnosis , Mycobacterium Infections, Nontuberculous/drug therapy , Mycobacterium Infections, Nontuberculous/complications , Cladribine/therapeutic use , Rifampin/therapeutic use , Azithromycin/therapeutic use , Rituximab/therapeutic use
2.
Org Lett ; 17(12): 3146-9, 2015 Jun 19.
Article in English | MEDLINE | ID: mdl-26068667

ABSTRACT

A highly efficient and feasible "condensation followed by annulation" synthetic approach was developed to afford a subset of 9-ring-fused quinacridone derivatives on a 10 g scale. Despite the amenable intermolecular hydrogen-bonding ability of these rigid molecules, good solubility in common organic solvents and solution processability into uniformed thin films were achieved. Integrated advantages in the synthesis and properties make these compounds ideal building blocks for high-performance dyes and optoelectronic materials.

SELECTION OF CITATIONS
SEARCH DETAIL